by using the patient's own cultured cells in combination with an optimal carrier material: BioSeed®-C is the result of BioTissue's research activities in the field of tissue engineering, as the first easy-to-use autologous 3-dimensional chondrocyte graft with unique shape stability, allowing for secure subchondral fixation. Excellent results have been shown, with up to 12 years of clinical follow-up data available.

using an intelligent matrix to support the body's own regenerative potential by providing an optimal environment for mesenchymal stem and progenitor cells. chondrotissue® is BioTissue's first smart matrix product: cell-free, stable, 3-dimensional scaffold, implantable through a one-step procedure, supporting the bone marrow-stimulating process after microfracture.